Guillermo Navarro
About
In The Last Decade
Guillermo Navarro
16 papers receiving 214 citations
Peers
Comparison fields: 5 of 66
- Pathology and Forensic Medicine 122
- Molecular Biology 79
- Neurology 55
- Cellular and Molecular Neuroscience 44
- Immunology 29
Countries citing papers authored by Guillermo Navarro
This map shows the geographic impact of Guillermo Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillermo Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillermo Navarro more than expected).
Fields of papers citing papers by Guillermo Navarro
This network shows the impact of papers produced by Guillermo Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillermo Navarro. The network helps show where Guillermo Navarro may publish in the future.
Co-authorship network of co-authors of Guillermo Navarro
This figure shows the co-authorship network connecting the top 25 collaborators of Guillermo Navarro. A scholar is included among the top collaborators of Guillermo Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillermo Navarro. Guillermo Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | 41 | |
| 5 | 15 | |
| 6 | 30 | |
| 7 | 6 | |
| 8 | 0 | |
| 9 | 4 | |
| 10 | 43 | |
| 11 | 46 | |
| 12 | 1 | |
| 13 | 7 | |
| 14 | [Evolution and adverse effects in patients with remittent-recurrent multiple sclerosis treated with interferon beta 1b. The influence of patient's weight and height]. | 2 |
| 15 | 3 | |
| 16 | [Progression of functional disability in 70 patients with multiple sclerosis]. | 1 |
| 17 | [Intrathecal secretion of antiviral antibodies in multiple sclerosis in patients in Seville]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.